認知機能・記憶向上薬市場：製品別、用途別、地域別、2025-2033年

認知機能・記憶向上薬市場の世界市場規模は2024年に61億7,160万米ドルに達しました。今後、IMARC Groupは、2033年までに市場は94億6,060万米ドルに達し、2025～2033年の成長率（CAGR）は4.86％になると予測しています。認知障害の有病率の増加、新規化合物や製剤を探索するための研究開発（R&D）活動の活発化、新規薬剤や革新的なドラッグデリバリー手法の導入などが、市場を牽引する主な要因です。

認知機能・記憶向上薬は、向精神薬やスマートドラッグとも呼ばれ、記憶力、注意力、創造性、総合的な精神能力などの認知機能を向上させることを目的としています。これらの医薬品は、脳の活動を強化し、より優れた認知能力を促進するように設計されています。特定の病状に対して処方されるほか、市販薬（OTC）や栄養補助食品としてオンラインで購入することもできます。脳内の特定の神経伝達物質の放出を増加させることで、覚醒度と集中力を高める。また、記憶や学習に重要なアセチルコリンレベルも高めます。抗酸化物質や抗炎症物質として作用し、脳を損傷から守り、最適な脳機能を促進します。また、明晰な思考を促し、認知処理速度を向上させ、意思決定能力の向上につながります。短期記憶と長期記憶を向上させ、情報の想起と保持を容易にします。また、生産性、効率性、認知能力を高めることで、学業や仕事のパフォーマンスを向上させるのにも役立ちます。

認知機能・記憶向上薬の市場傾向：

現在、アルツハイマー病、認知症、注意欠陥多動性障害（ADHD）などの認知障害の有病率が上昇していることは、市場の成長を支える重要な要因のひとつです。これに加えて、人々は脳の健康管理に積極的になり、認知能力を高める方法を求めるようになっており、これが認知機能・記憶向上薬の需要を刺激しています。さらに、認知機能や記憶力を高めることができる新しい化合物や製剤を探求する研究開発（R&D）活動が活発化していることも、市場の成長を後押ししています。これに伴い、新規薬剤や革新的なデリバリー方法の開発が消費者が利用できる選択肢の幅を広げ、市場の成長を強化しています。また、高齢者人口の増加に伴い、加齢に伴う認知機能の低下や記憶力の低下を緩和する薬剤に対する需要が高まっていることも、市場の見通しを良好なものにしています。これとは別に、学業や職業上のパフォーマンス向上を求める学生や専門家の間で認知機能・記憶向上薬の採用が増加していることは、業界の投資家にとって有利な成長機会を生み出しています。さらに、オンラインやオフラインの流通チャネルを通じて認知機能・記憶向上薬が広く入手可能であることが、市場の成長を強化しています。

本レポートで扱う主な質問

• 世界の認知機能・記憶向上薬の市場はこれまでどのように推移してきたか？
• 世界の認知機能・記憶向上薬の市場における促進要因、抑制要因、機会は何か？
• 各促進要因、抑制要因、機会が世界の認知機能・記憶向上薬の市場に与える影響は？
• 主要な地域市場とは？
• 最も魅力的な認知機能・記憶向上薬の市場はどの国か？
• 製品別の市場内訳は？
• 認知機能・記憶向上薬の市場で最も魅力的な製品は？
• 用途別の市場内訳は？
• 認知機能・記憶向上薬の市場で最も魅力的な用途は？
• 世界の認知機能・記憶向上薬の市場の競合構造は？
• 世界の認知機能・記憶向上薬の市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の認知機能・記憶向上薬市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品別

• アリセプト
• エクセロン
• ナメンダ
• ラザダイン
• プロビジル
• リタリン
• アデロール
• その他

第7章 市場内訳：用途別

• 疾患治療
• 運動能力
• 学習能力
• その他

第8章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第9章 促進要因・抑制要因・機会

• 概要
• 促進要因
• 抑制要因
• 機会

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第12章 価格分析

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • AbbVie Inc.
  • Biogen Inc.
  • Eisai Co Ltd.
  • Novartis AG
  • Takeda Pharmaceutical Company Ltd.

List of Figures

• Figure 1: Global: Cognitive and Memory Enhancer Drugs Market: Major Drivers and Challenges
• Figure 2: Global: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019-2024
• Figure 3: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 4: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Product (in %), 2024
• Figure 5: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Application (in %), 2024
• Figure 6: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Region (in %), 2024
• Figure 7: Global: Cognitive and Memory Enhancer Drugs (Aricept) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 8: Global: Cognitive and Memory Enhancer Drugs (Aricept) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 9: Global: Cognitive and Memory Enhancer Drugs (Exelon) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Cognitive and Memory Enhancer Drugs (Exelon) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Cognitive and Memory Enhancer Drugs (Namenda) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Cognitive and Memory Enhancer Drugs (Namenda) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Cognitive and Memory Enhancer Drugs (Razadyne) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Cognitive and Memory Enhancer Drugs (Razadyne) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Cognitive and Memory Enhancer Drugs (Provigil) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Cognitive and Memory Enhancer Drugs (Provigil) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Cognitive and Memory Enhancer Drugs (Ritalin) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Cognitive and Memory Enhancer Drugs (Ritalin) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Cognitive and Memory Enhancer Drugs (Adderall) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Cognitive and Memory Enhancer Drugs (Adderall) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Global: Cognitive and Memory Enhancer Drugs (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Global: Cognitive and Memory Enhancer Drugs (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Global: Cognitive and Memory Enhancer Drugs (Disease Treatment) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Global: Cognitive and Memory Enhancer Drugs (Disease Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Global: Cognitive and Memory Enhancer Drugs (Athletic Performance) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Global: Cognitive and Memory Enhancer Drugs (Athletic Performance) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Global: Cognitive and Memory Enhancer Drugs (Academic Performance) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Global: Cognitive and Memory Enhancer Drugs (Academic Performance) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Global: Cognitive and Memory Enhancer Drugs (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Global: Cognitive and Memory Enhancer Drugs (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: North America: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: North America: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: United States: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: United States: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Canada: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Canada: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Asia-Pacific: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Asia-Pacific: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: China: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: China: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Japan: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Japan: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: India: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: India: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: South Korea: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: South Korea: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: Australia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: Australia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: Indonesia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: Indonesia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: Europe: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: Europe: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Germany: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Germany: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: France: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: France: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: United Kingdom: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: United Kingdom: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Italy: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Italy: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 63: Spain: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: Spain: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 65: Russia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 66: Russia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 67: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 68: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 69: Latin America: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 70: Latin America: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 71: Brazil: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 72: Brazil: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 73: Mexico: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 74: Mexico: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 75: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 76: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 77: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 78: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market: Breakup by Country (in %), 2024
• Figure 79: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 80: Global: Cognitive and Memory Enhancer Drugs Industry: Drivers, Restraints, and Opportunities
• Figure 81: Global: Cognitive and Memory Enhancer Drugs Industry: Value Chain Analysis
• Figure 82: Global: Cognitive and Memory Enhancer Drugs Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Cognitive and Memory Enhancer Drugs Market: Key Industry Highlights, 2024 & 2033
• Table 2: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Product (in Million USD), 2025-2033
• Table 3: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 4: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 5: Global: Cognitive and Memory Enhancer Drugs Market: Competitive Structure
• Table 6: Global: Cognitive and Memory Enhancer Drugs Market: Key Players

The global cognitive and memory enhancer drugs market size reached USD 6,171.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 9,460.6 Million by 2033, exhibiting a growth rate (CAGR) of 4.86% during 2025-2033. The growing prevalence of cognitive disorders, increasing research and development (R&D) activities to explore new compounds and formulations, and introduction of novel drugs and innovative delivery methods represent some of the key factors driving the market.

Cognitive and memory enhancer drugs, also known as nootropics or smart drugs, aim to improve cognitive function like memory, attention, creativity, and overall mental performance. These drugs are designed to enhance brain activity and promote better cognitive abilities. They are available by prescription for specific medical conditions and can be purchased over the counter (OTC) or online as dietary supplements. They enhance alertness and focus by increasing the release of certain neurotransmitters in the brain. They also boost acetylcholine levels, which is important for memory and learning. They act as antioxidants or anti-inflammatory agents, protecting the brain from damage and promoting optimal brain function. They can also promote clearer thinking and improve cognitive processing speed and lead to better decision-making abilities. They assist in improving short-term and long-term memory, which makes it easier to recall and retain information. They also aid in enhancing academic or work performance by increasing productivity, efficiency, and cognitive abilities.

Cognitive and Memory Enhancer Drugs Market Trends:

At present, the rising prevalence of cognitive disorders, such as Alzheimer's disease, dementia, and attention deficit hyperactivity disorder (ADHD), represents one of the key factors supporting the growth of the market. Besides this, people are becoming more proactive in taking care of their brain health and seeking ways to enhance their cognitive abilities, which is catalyzing the demand for cognitive and memory enhancer drugs. Moreover, increasing research and development (R&D) activities to explore new compounds and formulations that can enhance cognitive functions and memory is propelling the growth of the market. In line with this, the development of novel drugs and innovative delivery methods is expanding the range of options available to consumers, which is strengthening the growth of the market. In addition, the growing demand for drugs that can alleviate age-related cognitive decline and memory loss due to the rising elderly population is offering a favorable market outlook. Apart from this, the increasing adoption of cognitive and memory enhancer drugs among students and professionals seeking improved academic and professional performance is creating lucrative growth opportunities for industry investors. Additionally, the wide availability of cognitive and memory enhancer drugs through online and offline distribution channels is strengthening the growth of the market.

Key Market Segmentation:

Product Insights:

• Aricept
• Exelon
• Namenda
• Razadyne
• Provigil
• Ritalin
• Adderall
• Others

Application Insights:

• Disease Treatment
• Athletic Performance
• Academic Performance
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cognitive and memory enhancer drugs. Some of the factors driving the North America cognitive and memory enhancer drugs market included the growing elderly population, increasing need to enhance focus, memory, and overall cognitive abilities, development of novel drugs, etc.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global cognitive and memory enhancer drugs market. Detailed profiles of all major companies have been provided. Some of the companies covered include AbbVie Inc., Biogen Inc., Eisai Co Ltd., Novartis AG, Takeda Pharmaceutical Company Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global cognitive and memory enhancer drugs market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global cognitive and memory enhancer drugs market?
• What is the impact of each driver, restraint, and opportunity on the global cognitive and memory enhancer drugs market?
• What are the key regional markets?
• Which countries represent the most attractive cognitive and memory enhancer drugs market?
• What is the breakup of the market based on the product?
• Which is the most attractive product in the cognitive and memory enhancer drugs market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the cognitive and memory enhancer drugs market?
• What is the competitive structure of the global cognitive and memory enhancer drugs market?
• Who are the key players/companies in the global cognitive and memory enhancer drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Cognitive and Memory Enhancer Drugs Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Aricept
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Exelon
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Namenda
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Razadyne
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Provigil
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Ritalin
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Adderall
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast
• 6.8 Others
  • 6.8.1 Market Trends
  • 6.8.2 Market Forecast

7 Market Breakup by Application

• 7.1 Disease Treatment
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Athletic Performance
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Academic Performance
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

• 9.1 Overview
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 AbbVie Inc.
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 Biogen Inc.
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
    • 13.3.2.4 SWOT Analysis
  • 13.3.3 Eisai Co Ltd.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 Novartis AG
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Takeda Pharmaceutical Company Ltd.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.